HBIO
Harvard Bioscience Inc
Price:  
9.09 
USD
Volume:  
46,781.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO EV/EBITDA

396.2%
Upside

As of 2026-11-10, the EV/EBITDA ratio of Harvard Bioscience Inc (HBIO) is 9.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HBIO's latest enterprise value is 71.54 mil USD. HBIO's TTM EBITDA according to its financial statements is 7.36 mil USD. Dividing these 2 quantities gives us the above HBIO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 19.3x - 30.4x 25.6x
Forward P/E multiples 29.3x - 42.2x 38.4x
Fair Price 24.53 - 61.68 45.10
Upside 169.9% - 578.5% 396.2%
9.09 USD
Stock Price
45.10 USD
Fair Price

HBIO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-11-06 9.27
2026-11-05 9.33
2026-11-04 9.42
2026-11-03 9.46
2026-11-02 9.41
2026-10-30 9.60
2026-10-29 9.54
2026-10-28 9.30
2026-10-27 9.26
2026-10-26 9.24
2026-10-23 9.19
2026-10-22 9.25
2026-10-21 9.35
2026-10-20 9.25
2026-10-19 9.10
2026-10-16 9.10
2026-10-15 9.24
2026-10-14 9.14
2026-10-13 9.21
2026-10-12 9.19
2026-10-09 9.19
2026-10-08 9.12
2026-10-07 9.35
2026-10-06 9.39
2026-10-05 9.35
2026-10-02 9.25
2026-10-01 9.12
2026-09-30 8.99
2026-09-29 9.02
2026-09-28 9.03
2026-09-25 9.02
2026-09-24 9.06
2026-09-23 9.07
2026-09-22 8.99
2026-09-21 9.04
2026-09-18 9.01
2026-09-17 9.06
2026-09-16 9.03
2026-09-15 9.04
2026-09-14 9.10
2026-09-11 9.06
2026-09-10 9.14
2026-09-09 9.01
2026-09-08 9.01
2026-09-04 9.06
2026-09-03 9.04
2026-09-02 9.17
2026-09-01 9.07
2026-08-31 9.11
2026-08-28 9.00